A Study of JNJ-87801493 in Combination With T-Cell Engagers in Participants With B-cell Non-Hodgkin Lymphoid (NHLs) Cancer
Clinical trial NCT06139406 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06139406
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-06
- Primary completion
- 2026-01-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.